Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
1hon MSN
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results